Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000939767-21-000106)

Filing Details

Accession Number:: 0000939767-21-000106
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-26 19:39:12
Reporting Period:: 2021-11-24

Accepted Time:: 2021-11-26 19:39:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
939767	Exelixis Inc.	EXEL	Biological Products, (No Disgnostic Substances) (2836)	043257395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1692954	J. Patrick Haley	C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502	Evp, Commercial	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-24	17,236	$17.25	237,802	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	23,539	Indirect	By spouse
Common Stock	10,648	Indirect	By 401(k)

Footnotes

Includes 132,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 23, 2021.